CA2102221A1 - Abrogation of viral resistance to nucleoside analogues by double-stranded rnas - Google Patents

Abrogation of viral resistance to nucleoside analogues by double-stranded rnas

Info

Publication number
CA2102221A1
CA2102221A1 CA002102221A CA2102221A CA2102221A1 CA 2102221 A1 CA2102221 A1 CA 2102221A1 CA 002102221 A CA002102221 A CA 002102221A CA 2102221 A CA2102221 A CA 2102221A CA 2102221 A1 CA2102221 A1 CA 2102221A1
Authority
CA
Canada
Prior art keywords
lock
azt
patient
mismatched dsrna
dsrna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002102221A
Other languages
English (en)
French (fr)
Inventor
William Carter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HEM Pharmaceuticals Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2102221A1 publication Critical patent/CA2102221A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CA002102221A 1991-04-16 1992-03-12 Abrogation of viral resistance to nucleoside analogues by double-stranded rnas Abandoned CA2102221A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68620091A 1991-04-16 1991-04-16
US686,200 1991-04-16

Publications (1)

Publication Number Publication Date
CA2102221A1 true CA2102221A1 (en) 1992-10-17

Family

ID=24755338

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002102221A Abandoned CA2102221A1 (en) 1991-04-16 1992-03-12 Abrogation of viral resistance to nucleoside analogues by double-stranded rnas

Country Status (10)

Country Link
EP (1) EP0581906A4 (pt)
JP (1) JPH06507624A (pt)
CN (1) CN1082819C (pt)
AU (1) AU671800B2 (pt)
CA (1) CA2102221A1 (pt)
IE (1) IE920873A1 (pt)
MX (1) MX9201711A (pt)
PT (1) PT100340A (pt)
WO (1) WO1992018004A1 (pt)
ZA (1) ZA922755B (pt)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4945082A (en) * 1985-08-26 1990-07-31 Hem Research, Inc. Controlled dsRNA therapy for human viral infections
US4795744A (en) * 1986-07-17 1989-01-03 Hem Research, Inc. Modulation of AIDS virus-related events by double-stranded RNAS
US4820696A (en) * 1985-08-26 1989-04-11 Hem Research, Inc. Modulation of aids virus-related events by double-stranded RNAS
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases

Also Published As

Publication number Publication date
EP0581906A1 (en) 1994-02-09
JPH06507624A (ja) 1994-09-01
AU671800B2 (en) 1996-09-12
IE920873A1 (en) 1992-10-21
AU1871892A (en) 1992-11-17
MX9201711A (es) 1992-10-01
ZA922755B (en) 1993-04-28
PT100340A (pt) 1993-07-30
EP0581906A4 (en) 1997-07-23
CN1082819C (zh) 2002-04-17
CN1068035A (zh) 1993-01-20
WO1992018004A1 (en) 1992-10-29

Similar Documents

Publication Publication Date Title
Bell et al. S‐adenosylmethionine blood levels in major depression: changes with drug treatment
IL171956A (en) Use of glatiramer acetate and mitoxantrone in the manufacture of medicaments for the treatment of multiple sclerosis
Spigset et al. Serotonin syndrome caused by a moclobemide-clomipramine interaction.
EA011420B1 (ru) Профилактика вич-инфекции
JP3237836B2 (ja) 抗ウイルス医薬組成物
Lowe et al. Hepatitis associated with terbinafine treatment.
WO1998019670A2 (en) Combination therapy of hepatitis c infections
Makwali et al. Combination and monotherapy of Leishmania major infection in BALB/c mice using plant extracts and herbicides
CA2102221A1 (en) Abrogation of viral resistance to nucleoside analogues by double-stranded rnas
Sheppard Moroxydine: the story of a mislaid antiviral.
Lawson et al. Life threatening drug reactions amongst medical in-patients
Janniger et al. Erythroderma as the initial presentation of the acquired immunodeficiency syndrome
Armitage et al. Maintenance of remission in adult acute nonlymphoblastic leukemia using intermittent courses of cytosine arabinoside (NSC-63878) and 6-thioguanine (NSC-752)
NZ260506A (en) Delaying and/or reducing appearance of nucleoside analogue resistance in a virus by administering matched or mismatched dsrna prior to nucleoside analogue therapy
KR20000005539A (ko) Dhea복합요법
NZ255735A (en) Treatment of hiv infection with il-4
Fishel et al. Fatal aplastic anaemia and liver toxicity caused by D-penicillamine treatment of rheumatoid arthritis.
Hall et al. Relative efficacy of hydrocortisone and methylprednisolone in acute severe asthma
Tan et al. Vaccine related glomerulonephritis.
Whitley Therapy of Varicella-Zoster Virus Infections
PT99962B (pt) Utilizacao de um medicamento anti-depressivo
Stinson et al. Ventricular asystole and overdose with atenolol.
Morton et al. Cortical blindness after nifedipine treatment.
ES2197923T3 (es) Composiciones de muramilpeptidos que inhiben la replicacion de vih.
Wei et al. (DXT56) Potential Weight Changes Among Patients with Multiple Sclerosis Undergoing Treatment with Ocrevus (Ocrelizumab).

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead